Treatments compared for advanced renal cell carcinoma

The placenta: The smoking gun in cardiovascular disease
3 December 2021
Scientists explain why neurons consume so much fuel even when at rest
3 December 2021

Treatments compared for advanced renal cell carcinoma

(HealthDay)—For patients with advanced renal cell carcinoma (aRCC), those initiating treatment with nivolumab plus ipilimumab versus sunitinib have longer treatment-free survival (TFS), according to a study published online Nov. 10 in Clinical Cancer Research.

Comments are closed.